We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
+21.73%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$351M
AUM Growth
-$60M
Cap. Flow
-$8.44M
Cap. Flow %
-2.41%
Top 10 Hldgs %
100%
Holding
9
New
Increased
Reduced
Closed
3

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$200M 56.91%
15,001,073
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$121M 34.4%
2,679,835
ALKS icon
3
Alkermes
ALKS
$8.82B
$13.7M 3.92%
892,400
INDA icon
4
iShares MSCI India ETF
INDA
$6.71B
$8.49M 2.42%
320,000
EPI icon
5
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$7.51M 2.14%
400,000
CLDX icon
6
Celldex Therapeutics
CLDX
$2.77B
$708K 0.2%
420,846
SDS icon
7
ProShares UltraShort S&P500
SDS
$406M
-4,600
Closed -$3.39M
SPXU icon
8
ProShares UltraPro Short S&P 500
SPXU
$436M
-1,050
Closed -$2.73M
SQQQ icon
9
ProShares UltraPro Short QQQ
SQQQ
$2.21B
-114
Closed -$2.32M

Similar funds

Meditor Group's Q4 2019 Portfolio in Review

As of Q4 2019, Meditor Group held 9 positions worth $351M, down 15% from $411M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Meditor Group's Q4 2019 filing shows 3 closed positions. The largest sale was ProShares UltraShort S&P500, an estimated $3.39M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 93% a quarter earlier.

  • Meditor Group fully exited ProShares UltraShort S&P500 in Q4 2019, selling an estimated $3.39M.
  • Meditor Group's ten largest holdings make up 100% of its $351M portfolio in Q4 2019.
  • Meditor Group opened 0 new positions and closed 3 in Q4 2019.
  • Meditor Group's portfolio value fell 15% quarter-over-quarter to $351M.

Based on Meditor Group's 13F filing for Q4 2019, filed 2 Jan 2020.